Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjie You

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Computers in Biology and Medicine|April 18, 2024
PLS-based gene subset augmentation and tumor-specific gene identificationWenjie You, Zijiang Yang, Guoli Ji
Plos One|February 18, 2014
MiRNAs as biomarkers of myocardial infarction: a meta-analysisChao Cheng, Qiang Wang, Wenjie You, et al.
Frontiers in Pharmacology|August 4, 2025
Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancerZicheng Guo, Wang Wang, Weikang Hu, et al.
Scientific Reports|April 6, 2017
Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1Wenjie You, Bi Chen, Xueqing Liu, et al.
Peerj|March 3, 2020
Glycyrrhizin suppresses epithelial-mesenchymal transition by inhibiting high-mobility group box1 via the TGF-<i>β</i>1/Smad2/3 pathway in lung epithelial cellsYanni Gui, Jian Sun, Wenjie You, et al.
Cancer Letters|October 28, 2017
The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancerXueqing Liu, Bi Chen, Wenjie You, et al.
Theranostics|August 4, 2025
Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to interventionHancheng Wu, Jing Li, Ruilin Yao, et al.
Oncology Reports|July 7, 2020
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)Wenjie You, Bin Shang, Jian Sun, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor MetastasisJi Zhou, Wenjie You, Guangqiang Sun, et al.
International Journal of Oncology|July 25, 2020
SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancerJing Li, Lifang Zhao, Yunjian Pan, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Computers in Biology and Medicine|April 18, 2024
PLS-based gene subset augmentation and tumor-specific gene identificationWenjie You, Zijiang Yang, Guoli Ji
Plos One|February 18, 2014
MiRNAs as biomarkers of myocardial infarction: a meta-analysisChao Cheng, Qiang Wang, Wenjie You, et al.
Frontiers in Pharmacology|August 4, 2025
Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancerZicheng Guo, Wang Wang, Weikang Hu, et al.
Scientific Reports|April 6, 2017
Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1Wenjie You, Bi Chen, Xueqing Liu, et al.
Peerj|March 3, 2020
Glycyrrhizin suppresses epithelial-mesenchymal transition by inhibiting high-mobility group box1 via the TGF-<i>β</i>1/Smad2/3 pathway in lung epithelial cellsYanni Gui, Jian Sun, Wenjie You, et al.
Cancer Letters|October 28, 2017
The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancerXueqing Liu, Bi Chen, Wenjie You, et al.
Theranostics|August 4, 2025
Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to interventionHancheng Wu, Jing Li, Ruilin Yao, et al.
Oncology Reports|July 7, 2020
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)Wenjie You, Bin Shang, Jian Sun, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2016
The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor MetastasisJi Zhou, Wenjie You, Guangqiang Sun, et al.
International Journal of Oncology|July 25, 2020
SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancerJing Li, Lifang Zhao, Yunjian Pan, et al.
Pageof 3